Filing Details
- Accession Number:
- 0001140361-18-003498
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-29 12:51:09
- Reporting Period:
- 2018-01-26
- Accepted Time:
- 2018-01-29 12:51:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231182 | P John Wareham | 571- North Turnabout Rd. Orange CA 92869 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Resmed Common Stock | Acquisiton | 2018-01-26 | 25,934 | $38.98 | 38,934 | No | 4 | M | Direct | |
Resmed Common Stock | Disposition | 2018-01-26 | 17,634 | $102.09 | 21,300 | No | 4 | S | Direct | |
Resmed Common Stock | Disposition | 2018-01-26 | 8,300 | $102.60 | 13,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Resmed Commmon Stock | Resmed Common Stock Options | Disposition | 2018-01-26 | 25,934 | $0.00 | 25,934 | $38.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-11-15 | 2019-11-15 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $101.49 to $102.49. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $102.49 to $102.73. The price reported above reflects the weighted average sale price.
- Represents the date options became exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.